ANDA Same-Day Filers Should Share Exclusivity, Industry Lawyer Says
This article was originally published in The Tan Sheet
Executive Summary
FDA should allow ANDA applicants who file the first Paragraph IV certifications against a patent on the same day to share 180-day exclusivity, industry attorney David Adams said at a Food & Drug Law Institute conference in Washington, D.C. April 2